tiprankstipranks

STEVEN KESTEN Insider Profile

4 Followers
STEVEN KESTEN, Exec VP and Chief MO at Plus Therapeutics, holds 55.20K shares in Plus Therapeutics (Ticker: PSTV).
tipranks
STEVEN KESTEN

STEVEN KESTEN
Plus Therapeutics (PSTV)
Exec VP and Chief MO

Not Ranked
STEVEN KESTEN has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$125K
100.00%
A breakdown of STEVEN KESTEN's holdings

Insider Roles

Plus Therapeutics
(PSTV)
Exec VP and Chief MO
Roles that STEVEN KESTEN holds in companies

Most Profitable Insider Trade

Stock:
Plus Therapeutics
(PSTV)
Rating:Informative Buy
Date:Aug 20, 2015 - Aug 20, 2016
Return:-62.30%
The most profitable trade made by STEVEN KESTEN

STEVEN KESTEN's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Plus Therapeutics
Feb 01, 2016
Exec VP and Chief MO
Uninformative Buy
$125.31K
Success Rate for
PSTV
0 out of 1 profitable transactions on
PSTV
0%
Average Return for
PSTV
Average return per transaction on
PSTV
-62.30%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Aug 19, 2015
Uninformative Buy
-
$43.04K
Aug 20, 2015
Informative Buy
$2.28K
-
$0.38
-62.30%
Feb 01, 2016
Uninformative Buy
$0.00
-
$0.00
List of latest transactions for each holding click on a transaction to see STEVEN KESTEN's performance on stock

STEVEN KESTEN insider profile FAQ

What is the percentage of profitable transactions made by STEVEN KESTEN?
The percentage of profitable transactions made by STEVEN KESTEN is ―.
    What is the average return per transaction made by STEVEN KESTEN?
    The average return per transaction made by STEVEN KESTEN is ―.
      What stocks does STEVEN KESTEN hold?
      STEVEN KESTEN holds: PSTV stocks.
        What was STEVEN KESTEN’s latest transaction?
        STEVEN KESTEN latest transaction was an Uninformative Buy of ―.
          What was STEVEN KESTEN's most profitable transaction?
          STEVEN KESTEN’s most profitable transaction was an Informative Buy of PSTV stock on August 20, 2015. The return on the trade was -62.30%.
            What is STEVEN KESTEN's role in Plus Therapeutics?
            STEVEN KESTEN's role in Plus Therapeutics is Exec VP and Chief MO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.